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Abstract
Disruption of the blood brain barrier (BBB) is a hallmark feature of immune-mediated neurological disorders as diverse as
viral hemorrhagic fevers, cerebral malaria and acute hemorrhagic leukoencephalitis. Although current models hypothesize
that immune cells promote vascular permeability in human disease, the role CD8 T cells play in BBB breakdown remains
poorly defined. Our laboratory has developed a novel murine model of CD8 T cell mediated central nervous system (CNS)
vascular permeability using a variation of the Theiler’s virus model of multiple sclerosis. In previous studies, we observed
that MHC class II




2/2, and TNFR1/TNFR2 double knockout
mice as well as those with inhibition of IL-1 and LTb activity were susceptible to CNS vascular permeability. Therefore, the
objective of this study was to determine the extent immune effector proteins utilized by CD8 T cells, perforin and FasL,
contributed to CNS vascular permeability. Using techniques such as fluorescent activated cell sorting (FACS), T1 gadolinium-
enhanced magnetic resonance imaging (MRI), FITC-albumin leakage assays, microvessel isolation, western blotting and
immunofluorescent microscopy, we show that in vivo stimulation of CNS infiltrating antigen-specific CD8 T cells initiates
astrocyte activation, alteration of BBB tight junction proteins and increased CNS vascular permeability in a non-apoptotic
manner. Using the aforementioned techniques, we found that despite having similar expansion of CD8 T cells in the brain as
wildtype and Fas Ligand deficient animals, perforin deficient mice were resistant to tight junction alterations and CNS
vascular permeability. To our knowledge, this study is the first to demonstrate that CNS infiltrating antigen-specific CD8 T
cells have the capacity to initiate BBB tight junction disruption through a non-apoptotic perforin dependent mechanism
and our model is one of few that are useful for studies in this field. These novel findings are highly relevant to the
development of therapies designed to control immune mediated CNS vascular permeability.
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Introduction
Disruption of the BBB is a hallmark feature of immune-
mediated neurological disorders as diverse as viral hemorrhagic
fevers, cerebral malaria and acute hemorrhagic leukoencephalitis
[1–6]. While immune-mediated CNS vascular permeability is a
likely contributor to pathology in neurologic disease, the role of
CD8 T cells in BBB breakdown under inflammatory conditions
remains largely undefined.
Studies using EM have determined that the healthy, intact
neurovascular unit (NVU) consists of cerebral endothelial cells
(CECs), basal lamina, astrocytic endfoot processes, pericytes and
neurons [7]. Among these cell types, pericytes and astrocytes have
the most direct interaction with vasculature. Astrocytic endfeet are
in contact with 90% of abluminal CECs [4,8]. In vitro and in vivo
studies support a role for astrocytes in controlling BBB
maintenance and regulation through their interaction with CECs
[9–13]. CEC tight junctions are composed of transmembranous
proteins including occludin, claudin-5 and the cytoplasmic
proteins zona occludens 1, 2 and 3 (ZO-1, ZO-2, ZO-3) [3].
Consistent with in vitro models, CNS vascular permeability
coincides with alteration of CEC tight junctions in rodent models
of BBB breakdown [3,14–16].
Although current models hypothesize that immune cells
promote opening of the BBB in human disease, the role of CNS
infiltrating antigen specific CD8 T cells in initiating vascular
permeability has not been determined. Expansion and global
activation of CD8 T cells has been observed in cases of viral
hemorrhagic fever, suggesting that these cells may play an
important role in vascular permeability [17–19]. To study the
interaction between CD8 T cells and the NVU under neuro-
inflammatory conditions, our laboratory has developed a novel
mouse model of CNS vascular permeability using a variation of
the Theiler’s murine encephalomyelitis virus (TMEV) model
commonly used to study multiple sclerosis [20–22]. Seven days
post TMEV infection, there is a massive expansion of CNS
infiltrating CD8 T cells specific for a 10 amino acid TMEV
peptide, VP2121–130, presented in the context of the D
b class I
molecule [23,24]. Intravenous administration of 0.1 mg of
VP2121–130 peptide seven days post infection results in severe
CNS vascular permeability in C57BL/6 mice, leading to mortality
within 48 hours [20]. In previous studies, we observed that major
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and TNFR1/TNFR2 double knockout mice were susceptible to
this fatal syndrome. We also determined that inhibition of
interleukin-1 and lymphotoxin-b activity did not protect mice
from becoming moribund. In contrast, perforin deficient mice did
not become moribund in this system [20]. These data indicated
that obvious candidate cytokines as well as CD4 T cell responses
were not necessary for the development of this fatal syndrome.
Therefore, the objective of this study was to determine the extent
immune effector proteins utilized by CD8 T cells, perforin and
FasL, contributed to CNS vascular permeability and the resultant
fatal syndrome.
In this paper, we present evidence that antigen specific CD8 T
cells have the capacity to initiate changes to the NVU as measured
by astrocyte activation and alteration of CEC tight junction
proteins. Our findings confirm that CD8 T cells specific for the
D
b:VP2121–130 epitope initiate CNS vascular permeability and
morbidity in C57BL/6 mice. Furthermore, we have determined
that this process is perforin dependent.
Results
TMEV infected C57BL/6, C57BL/6 Prf1
2/2 and C57BL/6
FasL
2/2 mice have comparable acute CD8 T cell
responses
To assess the CD8 T cell response of immune effector protein
deficient mice during acute TMEV infection, we performed flow-
cytometric analysis of lymphocytes isolated from the brain. Isolated
CNS infiltrating lymphocytes from 7 day TMEVinfected C57BL/6
(n=4), C57BL/6 Prf1
2/2 (n=4) and C57BL/6 FasL
2/2 (n=4)
mice were stained with antibody to CD8, CD44 and D
b:VP2121–130
tetramer or irrelevantD
b:E7 tetramer control. Using D
b:VP2121–130
tetramer staining, we determined that in the brains of C57BL/6,
C57BL/6 Prf1
2/2 and C57BL/6 FasL
2/2 mice, approximately
50–70% of CD44+ CD8+ T cells were specific for the D
b:
VP2121–130 epitope regardless of strain genotype (Figure 1A–C).
Irrelevant D
b:E7 tetramer did not appreciably stain CD8 T cells
(Figure 1D) [23]. We did not observe overt differences in the
number of isolated immune cells or frequencies of CD8+ cells
among the three genotypes (data not shown). These results
demonstrated that the expansion of CNS infiltrating D
b:VP2121–
130 epitope specific CD8 T cells was not markedly different between
C57BL/6, C57BL/6 Prf1
2/2 and C57BL/6 FasL
2/2 mice post
TMEV infection.
Vascular permeability is dependent on perforin
expression
We previously reported that C57BL/6 mice were susceptible to
becoming moribund following administration of VP2121–130
peptide seven days post TMEV infection. This peptide induced
a fatal syndrome was characterized by extensive vascular
permeability [20] We also determined in this study that C57BL/
6 Prf1
2/2 mice were resistant to becoming moribund, implying an
important role for effector molecules in mediating pathology
following induction of CD8 T cell mediated CNS vascular
permeability. To determine the extent of CNS vascular perme-
ability in C57BL/6 Prf1
2/2 mice, we employed in vivo high field
strength small animal magnetic resonance imaging (MRI) to assess
BBB integrity in the brains of C57BL/6, C57BL/6 Prf1
2/2 and
C57BL/6 FasL
2/2 mice, 24 hours post administration of
VP2121–130 or mock E7 peptide (Figure 2). Using T1-gadolinium
enhanced MRI we determined that C57BL/6 (Figure 2A, D) and
C57BL/6 FasL
2/2 (Figure 2C, F) mice had extensive vascular
permeability in the brain. In contrast, C57BL/6 Prf1
2/2 mice had
preserved vascular integrity as indicated by a lack of gadolinium
enhancement in the brain following VP2121–130 peptide adminis-
tration (Figure 3B, E).
MRI provided a qualitative analysis of vascular permeability in
C57BL/6, C57BL/6 Prf1
2/2, and C57BL/6 FasL
2/2 mice. To
enable a statistical analysis to test the hypothesis that C57BL/6
Prf1
2/2 mice were resistant to CNS vascular permeability using a
larger group of animals, we developed a liquid assay to analyze
whole brain lysates. Intravenous injection of FITC-albumin is a
method of quantifying CNS vascular permeability breakdown, as
albumin does not readily cross the BBB under normal condi-
tions[25]. This technique enabled us to quantify CNS vascular
permeabilityinbrainhomogenateswith an immunofluorescent plate
reader. C57BL/6, C57BL/6 Prf1
2/2, and C57BL/6 FasL
2/2
mice were administered E7 control peptide or VP2121–130 peptide to
induce CD8 T cell mediated vascular permeability. FITC-albumin
was then administered intravenously to E7 and VP2121–130 peptide
treated C57BL/6, C57BL/6 Prf1
2/2, and C57BL/6 FasL
2/2 mice
and allowed to circulate for one hour prior to brain harvest.
Harvested brains were homogenized and permeabilized to deter-
mine the extent of FITC-albumin leakage into the brain. We
observedsignificantincreases inFITC-albuminleakageinC57BL/6




(E7 n=4 mice, VP2 n=4 mice) mice 24 hours post VP2121–130
peptide administration (Figure 3K). These data demonstrated that
perforin but not FasL expression was necessary for VP2121–130
peptide induced CNS vascular permeability.
Astrocyte activation is dependant on perforin expression
Astrocytes have been demonstrated to regulate BBB integrity in
vitro and in vivo [9,10,13]. Therefore, we assessed astrocyte
activation in C57BL/6 and C57BL/6 Prf1
2/2 mice 24 hours
post administration of VP2121–130 or mock E7 peptide. As
demonstrated by microscopy, brains of C57BL/6 mice showed
glial fibrillary acidic protein (GFAP) expression by astrocytes in
regions with FITC-albumin leakage (Figure 3A–D). In contrast,
C57BL/6 Prf1
2/2 mice lacked an increase in GFAP expression
with VP2121–130 peptide treatment (Figure 3E–H). We assessed
GFAP protein levels in C57BL/6 and C57BL/6 Prf1
2/2 using
western blot analysis of whole brain lysates. These data showed a
significant increase in GFAP expression in C57BL/6 treated with
VP2121–130 peptide (n=3 mice) than with E7 control (n=4 mice)
(P,0.01) (Figure 3I). C57BL/6 Prf1
2/2 treated with VP2121–130
peptide (n=4 mice) did not have a significant increase in GFAP
expression when compared to E7 control (n=4 mice) (Figure 3J).
We determined from these experiments that perforin is necessary
for upregulation of GFAP following VP2121–130 peptide adminis-
tration.
Rapid NVU alterations precede peak increases in vascular
permeability
In the above experiments, we determined that administration of
the immunodominant VP2121–130 peptide post TMEV infection
resulted in astrocyte activation and vascular permeability. We next
performed a time course experiment to monitor the order in which
astrocyte activation, alteration of cerebral endothelial tight
junction protein levels, CNS vascular permeability and functional
deficit occurred. Using western blot analysis, we examined GFAP
protein (Figure 4C), occludin and claudin-5 protein (Figure 4E, F)
and active capase-3 protein (Figure 4D) at 0, 4, 12, and 24 hours
post VP2121–130 peptide administration in C57BL/6 mice. We also
examined FITC-albumin leakage (n=4 at 0,4,12,24 hours)
BBB Disruption by CD8 T Cells
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(n=16), 4 hours (n=12), 12 hours (n=8) and 24 hours (n=4)
following administration of VP2121–130 peptide. Astrocyte activa-
tion and tight junction protein alterations were observed as early
as 4 hours post administration of VP2121–130 peptide (Figure 4C,
E, F). CNS vascular permeability was greatest at 12 hours post-
VP2121–130 peptide administration as assessed by FITC-albumin
leakage. Ability to negotiate the rotarod decreased at 12 hours and
continued to decline until 24 hours. To determine if CECs were
undergoing apoptosis during peak levels of vascular permeability,
active caspase-3 protein levels were determined in the microvessel
lysates. We did not observe an overt increase in active caspase-3
until 24 hours in these lysates (n=4 at 0, 4, 12, 24 hours),
suggesting that activation of apoptosis does not occur until after
peak levels of permeability. Unlike perforin competent C57BL/6
mice, C57BL/6 Prf1
2/2 mice maintained tight junction expres-
sion levels of occludin and claudin-5 similar to controls for
24 hours post administration of VP2121–130 peptide (Figure 4G,
H). These data demonstrate that perforin expression is necessary
for tight junction alterations following administration of
VP2121–130 peptide. These results also indicate that astrocyte
activation and tight junction alterations develop prior to peak levels
of vascular permeability and functional impairment in this model.
Discussion
The observation that CD8 T cells contribute to vascular
permeability and utilize class I molecules to traffic to the CNS
extends beyond the TMEV model put forth in this study [26].
Clinical studies of human cerebral malaria have shown that tight
junction proteins are altered during infection similar to what we
observe in our model [6]. Animal models of cerebral malaria have
Figure 1. D
b:VP2121–130 epitope dominance among CNS infiltrating CD8 T cells isolated from the brain seven days post-TMEV
infection. Shown are brain infiltrating CD8+ cells isolated from (A) C57BL/6 mice, (B) C57BL/6 Prf1
2/2 mice and (C) C57BL/6 FasL
2/2 mice were
gated and analyzed for CD44 activation marker expression and D
b:VP2121–130 tetramer staining. In (D), C57BL/6 CD8+ cells were stained with negative
control D
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neuropathology [27]. Among the human viral hemorrhagic fevers,
dengue hemorrhagic fever (DHF) has been the most widely
studied. In DHF, considerable CD8 T cell activation, expansion
and apoptosis can be measured in the blood of DHF patients
during the peak of disease [17]. Additional epidemiological studies
among ethnic Thais have determined there is a genetic
predisposition to DHF which is linked to specific class I human
leukocyte antigen alleles [19]. Human leukocyte antigen class I
alleles contributing to a genetic predisposition have also been
observed in Haantavirus pulmonary syndrome among residents of
the Southwestern United States [18,28].
Previously, we reported that the majority of CNS infiltrating
CD8 T cells recognize the VP2121–130 peptide presented in the
context of the D
b class I molecule in seven day TMEV infected
C57BL/6 mice [23]. In ensuing studies designed to manipulate the
D
b:VP2121–130 epitope specific CD8 T cell response, we
determined that these antigen specific CD8 T cells could initiate
a fatal condition characterized by vascular permeability upon
administration of the VP2121–130 peptide during acute TMEV
infection [20]. Specific removal of this antigen specific population
of CD8 T cells protected mice from becoming moribund,
demonstrating the critical necessity of these cells in initiating this
fatal condition [20,24]. Using specific knockout mice and soluble
receptor techniques, we determined that this fatal condition was
not mediated by obvious cytokine candidates, including TNFa,
lymphotoxin-b and interleukin-1 [20].
We initially reported that perforin deficient mice had autofluo-
rescence in the hippocampal region of the brain and that this was
presumably due to vascular leakage of blood into the brain [20].
This was an unexpected finding given that perforin deficient mice
were protected from becoming moribund following VP2121–130
peptide administration. The current study was designed to revisit
this unexpected result using superior technology, including MRI,
established vascular permeability assays, and high-powered
microscopy. Using these established techniques to analyze BBB
disruption, we have determined that perforin is necessary for CNS
vascular permeability in this model and that autofluorescence is
not an appropriate method of analysis. The results obtained in the
current study are also consistent with preservation of functional
ability in perforin deficient mice after administration of VP2121–130
peptide [20]. Furthermore, the use of autofluorescence to monitor
CNS vascular permeability is not established in the literature. One
possibility is that the methodology used in the prior study played
an important role in the autofluorescence seen in the previous
study [20]. Mouse brains were fixed in 4% paraformaldehyde and
cut with a vibratome. In the present study, we used in vivo MRI
(figure 2), fresh frozen tissue homogenates for FITC-albumin
Figure 2. Vascular permeability following administration of VP2121–130 peptide is dependent on perforin expression. Analysis of
blood brain barrier disruption in a representative C57BL/6, C57BL/6 Prf1
2/2 and C57BL/6 FasL
2/2 mouse was analyzed with T1 weighted gadolinium-
enhanced MRI. Shown is the extent of gadolinium leakage in C57BL/6 (A, D), C57BL/6 Prf1
2/2 (B, E), and C57BL/6 FasL
2/2 (C, F) mice 24 hours post
administration of control E7 peptide or VP2121–130 peptide. Upper panels (A–C) denote E7 peptide administration, lower panels (D–F) denote
VP2121–130 peptide administration.
doi:10.1371/journal.pone.0003037.g002
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sections to visualize FITC-albumin leakage (figure 3). These assays
demonstrate that C57BL/6 Prf1
2/2 mice are resistant to CNS
vascular permeability in this model, suggesting a different
biological process was responsible for autofluorescence in the
previous study. It has been reported that oxidative damage to
erythrocytes can result in increased autofluorescence [29,30]. It is
therefore possible that administration of VP2121–130 peptide
initiates a perforin-independent mechanism that results in
oxidative activity in the CNS that may have been misconstrued
as vascular permeability. Nevertheless, it is important to note that
autofluorescence is not a reliable method for measuring vascular
leak under neuroinflammatory conditions.
In light of the discrepancy between past and present findings, we
further sought to define the importance of perforin expression in
promoting vascular permeability and functional impairment by
crossingmiceheterozygousforperforin(F1)withC57BL/6Prf1
2/2
mice. The resulting offspring were 50% heterozygous for the
Figure 3. Vascular permeability and astrocyte activation following administration of VP2121–130 peptide is dependent on perforin
expression. Tissue sections obtained from the brains of each animal were analyzed for astrocyte activation and vascular permeability as measured
by leakage of FITC albumin into the CNS and expression of GFAP. Shown is GFAP expression and the extent of FITC-Albumin leakage in the striatum
of E7 control or VP2121–130 peptide administered animals. Animals represented are (A) C57BL/6, E7 treatment, 56, (B) C57BL/6, E7 treatment, 636, (C)
C57BL/6, VP2121–130 treatment, 56, (D) C57BL/6, VP2121–130 treatment, 636, (E) C57BL/6 Prf1
2/2, E7 treatment, 56, (F) C57BL/6 Prf1
2/2, E7 treatment,
636, (G) C57BL/6 Prf1
2/2, VP2121–130 treatment, 56, (H) C57BL/6 Prf1
2/2, VP2121–130 treatment, 636, Western blot analysis of GFAP expression was
performed on whole brain lysates isolated from (I) C57BL/6 and (J) C57BL/6 Prf1
2/2 mice administered control E7 peptide or VP2121–130 peptide. (K)
Whole brain lysates obtained from C57BL/6, C57BL/6 Prf1
2/2 and C57BL/6 FasL
2/2 mice administered control E7 peptide or VP2121–130 peptide were
analyzed for FITC albumin leakage using a fluorescent plate reader at 488 nm excitation and 525 nm emission.
doi:10.1371/journal.pone.0003037.g003
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24 hours post administration of VP2121–130 peptide, C57BL/6 mice were analyzed for (A) FITC-Albumin leakage in whole brain, (B) motor performance
using rotarod analysis, (C) GFAP expression in whole brain, (F) Occludin protein levels in isolated brain microvessels, (E) Claudin-5 protein levelsi n
isolated brain microvessels and (D) active caspase-3 protein levels in isolated brain microvessels. Mice were analyzed with rotarod analysis (B) just
prior to harvesting CNS tissue. Also shown are 24 hours post-administration of control E7 peptide or VP2121–130 peptide in C57BL/6 Prf1
2/2 mouse
tight junction protein levels of (G) claudin-5, (H) occludin.
doi:10.1371/journal.pone.0003037.g004
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of experiments put forward in this paper, perforin heterozygosity
predisposed these animals to undergo vascular permeability shown
by FITC-albumin leakage (P,0.01) and functional impairment on
the rotarod (P,0.01) when compared toperforindeficient littermate
controls (data not shown). This experiment demonstrates that only
one perforin allele is necessary to induce this syndrome and
minimizes thelikelihoodofothercontributingallelesonthe C57BL/
6P r f 1
2/2 mouse background that may have resulted through
genetic drift or incomplete crossing from the 129 svlm mouse
background.
To understand the state of tight junction proteins in our model
of CNS vascular permeability we utilized a well established
method of rodent brain microvessel isolation [31–33]. Microvessel
isolation from brain tissue enabled the analysis of BBB tight
junction protein levels in the CNS. Assessment of tight junction
protein levels in brain microvessels isolated from C57BL/6 and
C57BL/6 Prf1
2/2 mice demonstrated that perforin was necessary
for alteration of BBB tight junction protein levels in C57BL/6
mice. In these assays, we observed a decrease in occludin protein
as early as 4 hours post VP2121–130 peptide administration and an
increase in claudin-5 by 24 hours in C57BL/6 mice (Figure 4).
These data are significant because decreased transendothelial
electric resistance indicative of increased paracellular permeability
has been observed in in vitro BBB models with compromised
occludin expression [34]. Furthermore, claudin-5 has been
hypothesized to play a role in tight junction formation and is
predominantly expressed in CECs rather than nonvascular CNS
tissue [35,36]. Using the same microvessel isolation technique in a
murine model of chronic inflammatory pain also resulted in
decreased occludin and increased claudin-5 expression when BBB
breakdown was initiated [37–39]. Although our model of CNS
vascular permeability is initiated by CNS infiltrating antigen
specific CD8 T cells through a process dependent on perforin, our
data supports these previous findings that alteration of tight
junction protein levels is concurrent with BBB disruption.
We have determined through preliminary studies, that low
levels of vascular permeability are occurring as a result of TMEV
infection in the CNS (data not shown). This preliminary work
suggests that intravenously injected VP2 peptide has access to the
CNS through low levels of BBB permeability potentially resulting
in heightened activation of CNS infiltrating CD8 T cells in this
model. We previously reported a significant reduction in
D
b:VP2121–130 epitope specific CD8 T cells, one day following
VP2 peptide administration in both C57BL/6 and 129 SvIm
strains of mice, demonstrating a rapid effect of VP2 peptide on
CNS infiltrating CD8 T cell responses [20]. Additionally, the T1
gadolinium-enhanced MRI analysis put forth in this study further
supports the capacity of CNS infiltrating CD8 T cells in altering
the BBB. We consistently observe that the hemisphere intracra-
nially injected with TMEV has more pronounced vascular
permeability compared to the contralateral side (Figure 2 and
data not shown). This specific regional enhancement near areas of
virus injection suggests that high levels of viral replication, antigen
processing and antigen presentation to CD8 T cells in the CNS
tissue predisposes specific regions of the brain to be susceptible to
vascular permeability. This MRI study coupled with our previous
work which determined that the majority of D
b:VP2121–130 epitope
specific CD8 T cells are predominantly found in the brain 7 days
post TMEV infection and not in peripheral lymphoid compart-
ments, supports the concept that active engagement of T cell
receptor with antigen in the CNS is a likely contributor to vascular
permeability following administration of intravenous VP2121–130
peptide [20,23]. Previous demonstration of normal hematocrit
levels and a lack of pathology in peripheral organs in this model
further supports such a hypothesis [20].
C57BL/6 Prf1
2/2 mice have negligible astrocyte activation,
normal levels of tight junction proteins and the absence of CNS
vascular permeability following administration of VP2121–130
peptide administration. These data demonstrate a critical role
for perforin in disruption of the NVU which results in CNS
vascular permeability. We hypothesize that CNS infiltrating CD8
T cells are hyper-stimulated by the presence of excess VP2121–130
peptide antigen presented on D
b class I molecules in the CNS.
These D
b:VP2121–130 epitope specific CD8 T cells then utilize
perforin to deliver inflammatory components which ultimately
result in activation of cellular components of the NVU, leading to
rapid alteration of BBB tight junction proteins. This results in CNS
vascular permeability and decreased ability to negotiate the
rotarod (Figures 2, 3).
An alternative model is that CD8 T cells destroy vascular CECs
directly through direct perforin-mediated killing. Studies in
murine cerebral malaria have found that perforin deficient mice
are resistant to CEC damage, as assessed by active caspase-3
staining. The authors demonstrate that caspase-3 activation in
CECs occurred simultaneously with edema and petechial
hemorrhage and that this process was perforin dependent [27].
We also observed caspase-3 activation in microvessel isolates at
24 hours post VP2121–130 peptide administration when the
C57BL/6 mice were moribund. However, the onset of FITC-
albumin leakage occurs much earlier, peaking at 12 hours post
administration of VP2121–130 peptide which is considerably earlier
than observable active caspase-3 in microvessel isolates (Figure 4).
Our kinetic analysis therefore does not readily support a
mechanism in which caspase-3 mediated apoptosis is the initiator
of CNS vascular permeability. Furthermore, while we observed
decreases in microvessel occludin following VP2121–130 peptide
administration, Claudin-5 levels dramatically increased. These
data suggest that CECs remained viable and capable of protein
expression while peak permeability was occurring (Figures 4). Our
analysis of tight junction proteins and active caspase-3 protein in
microvessel isolates supports a model in which perforin mediates
vascular permeability through a mechanism that is not directly
apoptotic to the vasculature or utilizes a pathway that does not
involve caspase-3 activation. A non-apoptotic role for perforin has
been previously implied in studies demonstrating the capacity of
CD8 T cells to control Herpes simplex virus replication in
ganglionic neurons through a mechanism that does not result in
apoptosis [40,41]. Extending this observation to other CNS cell
types enables one to hypothesize that perforin could potentially
deliver inflammatory factors to CNS cell types, including cellular






2/2) mice were obtained from Jackson
laboratories at 6 weeks of age. All experiments were approved by
the IACUC of University of Cincinnati.
Induction of CNS vascular permeability
CNS vascular permeability was induced as described previously
[20]. Briefly, all mice were infected intracranially with 2610
6 PFU
Daniel’s strain of TMEV. 7 days post-TMEV infection, mice were
injected intravenously with 0.1 mg VP2121–130 (FHAGSLLVFM) or
mock control E7 (RAHYNIVTF) peptide (Genscript) [20].
BBB Disruption by CD8 T Cells
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Animals were placed on the Rotamex-5 rotarod apparatus
(Columbus Instruments) increasing from 5–40 RPMs over 7 min-
utes. This behavioral assay has been well established as a means to
assess overall functional ability in mice ([42,43]. For multiple time
points rotarod score is represented as seconds on rotarod at 0,4,12
and 24 hours post-VP2121–130 peptide administration (Figure 4).
FITC-albumin Permeability Assay
Mice were injected intravenously with 10 mg FITC-albumin
(Sigma #A9771) 23 hours after VP2121–130 peptide administration
and brains were harvested at 24 hours. Brains were cut using a
cryostat at 220uC. All sections not mounted on slides were used to
make homogenates as described in Western blots method (minus
brainstem). Homogenates were read on a fluorescent plate reader
at 488 nm excitation and 525 nm emission. Data was collected
using SpectraMax software (Molecular Devices).
Western Blots
Brain tissue samples were lysed in radioimmunoprecipitation
assay (RIPA) buffer [10 mmol/L Tris, 140 mmol/L NaCl, 1%
Triton X-100, 1% Na deoxycholate, 0.1% SDS and protease
inhibitor cocktail (Pierce #78410) pH 7.5] and centrifugated for
15 min at 10,000 RPM. Samples were normalized using the BCA
protein assay (Pierce #23223) and prepared using the method of
Laemmli [44]. For GFAP detection, 10 ug of protein was loaded
per well on 4–20% precise protein gels (Pierce #25244) with
BupH Tris-HEPES-SDS running buffer (Pierce #28398). Gels
were transferred onto Immun-Blot PVDF membranes (Biorad
#162-0177) using Tris transfer buffer [400 mmol/mL Tris base,
70 mmol/mL glycine, 10% methanol]. Mouse anti-GFAP (1:1000
BD Pharmingen #556329) and goat anti-mouse IgG conjugated
to horseradish peroxidase were used to detect GFAP (Sigma
#A3682). Western blot films were analyzed by densitometry using
Scion Image software (Scion Corp). Background was subtracted
from each band and data is expressed in arbitrary units (AU).
Microvessel isolation and tight junction, active caspase-3
western blots
Microvessel isolation based on protocol previously described by
Brooks et al. [33]. Briefly, hemispheres ipsilateral or contralateral
to the intracranial TMEV injection site were homogenized in
microvessel isolation buffer, 26% dextran was added and samples
were centrifuged for 10 minutes at 6874 RPM. Supernatants were
discarded and pellet was resuspended in microvessel isolation
buffer. Samples were centrifuged at 5010 RPM (Sorvall Super-
speed SS-34 rotor) for 10 minutes. Pellets were resuspended in
6 M urea and digested overnight at 4uC. Protein concentration
was determined using a BSA standard curve and 4 ug or 8 ug was
added per well as described previously. For tight junction analysis,
blots were probed using rabbit anti-occludin, claudin-5 (Zymed) at
1:500. Goat anti-rabbit conjugated to horseradish peroxidase
(Santa Cruz #sc 2004) was used to detect primary antibody. For
active Caspase-3 detection, 30 ug protein was loaded per well on
4–20% Tris-HCL Criterion precast gels (Bio-Rad #345-0033).
Gels ran in Tris-SDS running buffer and were transferred onto
Immun-Blot PVDF membranes (Biorad #162-0177) using Tris
transfer. Rabbit anti-active Caspase-3 (BD Biosciences #557038)
and goat anti-rabbit conjugated to horseradish peroxidase (Santa
Cruz #sc 2004) was used to detect active caspase-3 protein.
Western blot films were analyzed by densitometry as described
above.
Immunofluorescent microscopy
Tissue sections from FITC-albumin injected mice were fixed in
220uC 95% ethanol at 4uC for 15 minutes and washed with
repeated changes in .01 M PBS for 2 hours. Sections were blocked
in 10% normal goat serum (in 0.1 M PBS+.03% Triton X-100) for
1 hour. Sections were incubated in mouse anti-GFAP conjugated
to cy-3 (Sigma C-9205) overnight at 4uC in humid chamber.
Sections were washed in 0.1 M PBS for 1 hour and air dried for
1.5 hours. Fluoromount (Southern Biotech 0100-01) was used to
mount coverslips. Sections were imaged at room temperature at
56and 636using the Orca ER Zeiss upright microscope. Images
were captured using Orca-ER CCD camera and Metamorph
Software (Molecular Devices Corporation) at the Center for
Biological Microscopy at University of Cincinnati, College of
Medicine.
Flow cytometry
Seven days post TMEV infection, brain-infiltrating lymphocytes
were isolated from mouse brain through collagenase digestion and
a percoll gradient as previously described [45]. Allophycyanin
(APC) D
b:VP2121–130 tetramer and APC D
b:E7 tetramer were
constructed as previously published and used in conjunction with
anti-CD8-FITC (BD #553031) and anti-CD44-PE (BD #553134)
[23]. Samples were read on a BD LSR II flow cytometer (Becton
Dickinson) and analyzed with BD FACS Diva 6.0 software (BD
Biosciences). In all panels, the CD8+ T cell population was gated
and analyzed for CD44+ (activation) and D




MRI acquisition was performed in a horizontal bore Bruker 7
Tesla microimaging system. Volume acquisition of the entire
mouse brain was performed pre- and post-gadolinium contrast dye
injection using a T1 weighted spin echo sequence (TR200ms,
TE10ms, FOV: 462.562.5 cm, matrix: 25661286128, NEX 2)
to determine the overall volume of gadolinium enhancing areas
(areas with increased BBB permeability).
Statistical Analysis
Mean and standard error values for rotarod scores, FITC-
albumin quantification and western blot quantification were
calculated using software program SigmaStat(SYSTAT software
Inc). Bar graphs with standard error values were plotted on
software program SigmaPlot (SYSTAT software Inc). To
determine significance between groups, a student’s t-test was
performed between E7 and VP2121–130 within the same strain
using SigmaPlot.
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